Cuimin Ding
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Mitochondrial Function and Pathology
- Extracellular vesicles in disease
Papers in
-
- Lung Cancer Treatments and Mutations 8
- Lung Cancer Diagnosis and Treatment 3
-
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 3
- Co-authors
- Zhanjun Guo (4 shared papers)Ruijuan Li (3 shared papers)Shengmian Li (2 shared papers)Bin Li (5 shared papers)Bin Li (2 shared papers)Hui Ge (2 shared papers)Ping Wang (1 shared paper)Hao Jin (1 shared paper)
- Journals
- Oncology Reports (2 papers)Scientific Reports (1 paper)BMC Medicine (1 paper)Annals of Translational Medicine (1 paper)PeerJ (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Cuimin Ding
31 papers receiving 341 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 124
- Molecular Biology 178
- Oncology 58
- Pulmonary and Respiratory Medicine 47
- Immunology 13
Countries citing papers authored by Cuimin Ding
This map shows the geographic impact of Cuimin Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuimin Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuimin Ding more than expected).
Fields of papers citing papers by Cuimin Ding
This network shows the impact of papers produced by Cuimin Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuimin Ding. The network helps show where Cuimin Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Cuimin Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 37 | |
| 2 | 2012 | 34 | |
| 3 | MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival. | 2015 | 32 |
| 4 | 2018 | 31 | |
| 5 | 2023 | 21 | |
| 6 | 2013 | 21 | |
| 7 | 2018 | 20 | |
| 8 | 2020 | 18 | |
| 9 | 2016 | 18 | |
| 10 | 2016 | 12 | |
| 11 | 2012 | 11 | |
| 12 | 2021 | 11 | |
| 13 | 2020 | 11 | |
| 14 | 2016 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2021 | 7 | |
| 17 | 2021 | 7 | |
| 18 | 2018 | 6 | |
| 19 | 2019 | 5 | |
| 20 | [The interleukin-6 level in exhaled breath condensate of patients with obstructive sleep apnea-hypopnea syndrome]. | 2005 | 4 |
About Cuimin Ding
Cuimin Ding is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Epidemiology, having authored 31 papers that have together received 341 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), MicroRNA in disease regulation (7 papers), Lung Cancer Research Studies (6 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), Lung Cancer Diagnosis and Treatment (3 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (124 citations), Molecular Biology (178 citations), Oncology (58 citations), Pulmonary and Respiratory Medicine (47 citations) and Immunology (13 citations). Cuimin Ding has collaborated with scholars based in China and United States. Frequent co-authors include Zhanjun Guo, Ruijuan Li, Shengmian Li, Bin Li, Bin Li, Hui Ge, Ping Wang, Hao Jin, Wei Liu and Mengmeng Gao. Their work appears in journals such as Oncology Reports, Scientific Reports, BMC Medicine, Annals of Translational Medicine and PeerJ.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.